-
501
-
502
-
503
SSF-DDI: a deep learning method utilizing drug sequence and substructure features for drug–drug interaction prediction
Published 2024-01-01“…Abstract Background Drug–drug interactions (DDI) are prevalent in combination therapy, necessitating the importance of identifying and predicting potential DDI. …”
Get full text
Article -
504
-
505
Risk of Adverse Drug-Drug Interactions in Heart Failure Patients with Co-morbidity Chronic Kidney Disease Prescribed Polypharmacy
Published 2023-01-01Subjects: Get full text
Article -
506
Overview of Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Targeted Therapy and Supportive Care for Lung Cancer
Published 2023-02-01Subjects: “…Drug-drug interaction…”
Get full text
Article -
507
No drug–drug interactions between selective prolyl‐tRNA synthetase inhibitor, bersiporocin, and pirfenidone or nintedanib in healthy participants
Published 2024-01-01“…To validate the combination therapy of bersiporocin with pirfenidone or nintedanib, a randomized, open‐label, two‐part, one‐sequence, three‐period, three‐treatment study was designed to evaluate the effect of drug–drug interactions (DDI) regarding their pharmacokinetics, safety, and tolerability in healthy participants. …”
Get full text
Article -
508
TOPS: a versatile software tool for statistical analysis and visualization of combinatorial gene-gene and gene-drug interaction screens
Published 2014“…Dataset 1 is a gene-drug interaction screen and is based on Luminex xMAP technology. …”
Journal article -
509
Retrospective cohort observation on psychotropic drug-drug interaction and identification utility from 3 databases: Drugs.com®, Lexicomp®, and Epocrates®
Published 2023-01-01“…The psychotropic drug-drug interaction (DDI) should be concerned and efficiently monitored by a proper instrument. …”
Get full text
Article -
510
Evaluation of the potential herb-drug interaction between Bojungikki-tang and PD-L1 immunotherapy in a syngeneic mouse model
Published 2023-05-01Subjects: Get full text
Article -
511
Potential Drug-Drug Interactions among Patients with Schizophrenia Spectrum Disorders: Prevalence, Association with Risk Factors, and Replicate Analysis in 2021
Published 2023-02-01Subjects: “…potential drug—drug interactions…”
Get full text
Article -
512
Drug Utilization and Potential Drug-Drug Interactions within an Intensive Care Unit at a University Tertiary Care Hospital in Egypt
Published 2022-08-01Subjects: Get full text
Article -
513
Prevalence and Predictors of Potential Drug-Drug Interactions in the Elderly: A Cross-Sectional Study in the Brazilian Primary Public Health System
Published 2012-05-01“…The primary objective of this study was to investigate the prevalence of clinically important potential drug-drug interactions (DDIs) in elderly patients attending the public primary health care system in Brazil. …”
Get full text
Article -
514
-
515
Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors
Published 2020-09-01Subjects: Get full text
Article -
516
Retrospective cohort observation on psychotropic drug-drug interaction and identification utility from 3 databases: Drugs.com®, Lexicomp®, and Epocrates®.
Published 2023-01-01“…The psychotropic drug-drug interaction (DDI) should be concerned and efficiently monitored by a proper instrument.…”
Get full text
Article -
517
Developing a mechanistic understanding of the nonlinear pharmacokinetics of letermovir and prospective drug interaction with everolimus using physiological‐based pharmacokinetic modeling
Published 2023-06-01“…This PBPK model was further used to evaluate the drug interaction potential between letermovir and everolimus, an immunosuppressant that may be co‐administered with letermovir depending on regions. …”
Get full text
Article -
518
Risk of multiple drug interactions potentially linked to safety in patients receiving pangenotypic direct-acting antivirals for the treatment of Hepatitis C
Published 2022-12-01“…Introduction and Objectives: Previous studies have evaluated the risk of drug-drug interactions (DDI) in HCV patients receiving pangenotypic direct-acting antivirals (pDAA), but all are based on pairwise interaction. …”
Get full text
Article -
519
A Physiologically Based Pharmacokinetic and Pharmacodynamic Model of the CYP3A4 Substrate Felodipine for Drug–Drug Interaction Modeling
Published 2022-07-01Subjects: Get full text
Article -
520